Catalyst Wire Dossier Catalyst Wire Dossier

ZKY001 Eye Drops

· Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ZKY001 Eye Drops, covering 2025-01-15 to 2025-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect [Phase 1]

See pricing